News Releases
Jan 9 2003
Peregrine Pharmaceuticals Reduces Clinical Department
Jan 6 2003
Peregrine To Develop Vascular Targeting Agents (VTA) With Schering AG
Dec 12 2002
Peregrine Announces Quarterly Conference Call
Dec 10 2002
Peregrine's Non-Radiolabeled Lym-1 Antibody Shows Significant Anti-Tumor Effect on B-Cell Lymphoma in Preclinical Studies
Dec 9 2002
Peregrine's Phosphatidylserine-Based Vascular Targeting Agent Technology Published In International Journal of Radiation - Oncology - Biology - Physics
Nov 25 2002
Peregrine Pharmaceuticals Receives Orphan Drug Designation For Cotara(TM) In Europe
Nov 19 2002
Avid Bioservices Presents at IBC Biopharmaceutical Production Week Conference
Nov 15 2002
Vascular Targeting Agent Approach to Targeted Therapy Published in The Pharmacogenomics Journal
Nov 13 2002
Peregrine's Anionic Phospholipid Based Vascular Targeting Agent Technology Published in Cancer Research
Nov 1 2002
Peregrine Pharmaceuticals Provides Update On Status Of Cotara Phase III